JG
RARE icon

Jefferies Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jefferies Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,000
Closed -$391 – 1510
2020
Q2 		$391 Buy
+5,000
New +$331K ﹤0.01% 959
2016
Q4 		– Sell
-17,600
Closed -$1.25M – 2424
2016
Q3 		$1.25M Sell
17,600
-9,200
-34% -$587K 0.01% 1175
2016
Q2 		$1.31M Hold
26,800
– – 0.01% 1052
2016
Q1 		$1.7M Buy
+26,800
New +$1.75M 0.01% 925
2015
Q4 		– Sell
-39,700
Closed -$3.82M – 2509
2015
Q3 		$3.82M Buy
+39,700
New +$4.55M 0.02% 606

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return